Mounjaro ~22.5% average body weight loss Significant weight reduction Improves blood sugar levels Clinically proven weight loss Wegovy ~16.9% average body weight loss Boosts metabolic & cardiovascular health Proven, long-established safety profile Weekly injection, easy to use
Medical spas
PubMed Chromium 53 references Cerulli J, Grabe DW, Gauthier I, et al
Where to learn more For clinicians: seek continuing education on metabolic medicine, peptide pharmacology, and gutbrain interactions
GLP-1 receptor agonists (RA), such as Ozempic and Mounjaro, were initially designed to help manage blood sugar in type 2 diabetes
The relationship between GLP-1 therapy and joint pain relief appears to be multifactorial rather than a direct pharmacological effect on joint tissues